References
- Bringing Research in Diabetes to Global Environments and Systems—International Diabetes Foundation. 2007 (http://www.idfbridges.org/supported-projects). Website accessed on 23 February 2010.
- IDF and Eli Lilly and Company Partner to Uncover Practical Solutions for Better Diabetes Outcomes—Press Release. 5 December 2006 (http://www.idf.org/node/1351?unode=1D292091-67DA-48BB-81B0-73112469D36E). Website accessed on 23 February 2010.
- Welcome to BRIDGES (http://www.idfbridges.org/). Website accessed on 23 February 2010.
- BRIDGES IDF Grant Research Programme Fact Sheet (www.idf.org/webdata/docs/BRIDGES%20Fact%20Sheet.doc). Website accessed on 23 February 2010.
- Katzenellenbogen L, Blaauw R, Steyn N. Assessment of the Perceived impact of Diabetes on Quality of Life in a Group of South African Diabetic Patients. December 2008 (http://etd.sun.ac.za/jspui/bitstream/10019/1947/3/Katzenellenbogen%2c%20L.pdf). Website accessed on 23 February 2010.
- BRIDGES IDF Grant Research Programme Timeline of Key Dates (www.idf.org/…/BRIDGES%20Timeline%20of%20Grant%20Program.doc). Website accessed on 23 February 2010.
- About Lilly (http://www.lillydiabetes.com/content/about-lilly.jsp). Website accessed on 23 February 2010.
References
- Ed. Incretin therapy: a new treatment modality in the fight against the worldwide diabetes epidemic. Drug Trends. SA Journal of Diabetes & Vascular Disease 2009; 6(2): 83–84.
- Holst JJ, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 2004; 287.
- Zander M, Christiansen A, Madsbad S, Holst JJ. Additive effect of glucagon-like peptide-1 and pioglitazone in patients with type 2 diabetes. Diab Care 2004; 27: 1910–1914.
- D'Alessio D, Sandoval D, Seeley R. New ways in which GLP-1 can regulate glucose homeostasis. J Clin Invest 2007; 115(12): 3406–3408.
- Byetta package insert.
Reference
- : Amtas package insert. Reg. Nos.: 41/7.1/0659, 41/7.1/0660
Reference
- : Rispacor package insert.